Fennec Pharmaceuticals (FENC) Profit After Tax (2016 - 2025)
Historic Profit After Tax for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to -$638000.0.
- Fennec Pharmaceuticals' Profit After Tax rose 8887.53% to -$638000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.9 million, marking a year-over-year decrease of 51253.31%. This contributed to the annual value of -$436000.0 for FY2024, which is 9728.26% up from last year.
- According to the latest figures from Q3 2025, Fennec Pharmaceuticals' Profit After Tax is -$638000.0, which was up 8887.53% from -$3.2 million recorded in Q2 2025.
- Fennec Pharmaceuticals' 5-year Profit After Tax high stood at $12.8 million for Q1 2024, and its period low was -$10.3 million during Q4 2022.
- Its 5-year average for Profit After Tax is -$3.4 million, with a median of -$4.1 million in 2021.
- Examining YoY changes over the last 5 years, Fennec Pharmaceuticals' Profit After Tax showed a top increase of 31211.17% in 2024 and a maximum decrease of 20717.73% in 2024.
- Over the past 5 years, Fennec Pharmaceuticals' Profit After Tax (Quarter) stood at -$4.2 million in 2021, then tumbled by 145.15% to -$10.3 million in 2022, then soared by 74.04% to -$2.7 million in 2023, then grew by 25.99% to -$2.0 million in 2024, then skyrocketed by 67.86% to -$638000.0 in 2025.
- Its Profit After Tax stands at -$638000.0 for Q3 2025, versus -$3.2 million for Q2 2025 and -$1.2 million for Q1 2025.